The Ministry of Health and Social Protection has issued Resolution 814 of 2026, regulating the ban on animal testing for cosmetic products, their ingredients, and combinations, in compliance with Law 2047 of 2020. This measure represents a decisive step by transforming a general legal provision into a technical and operational requirement enforceable within Colombia’s health regulatory system.
The resolution establishes that all stakeholders in the supply chain—manufacturers, importers, exporters, and distributors—must submit a first-party declaration of conformity to INVIMA as a requirement for obtaining the Mandatory Health Notification (NSO). In this document, the holder certifies that the cosmetic products, their ingredients, and mixtures
have not been tested on animals, assuming direct responsibility for the accuracy of such statement.
With this provision, compliance becomes verifiable by the health authority, which may exercise control both during the approval process and in the marketplace. Additionally, the absence of this requirement will prevent progress in importation, manufacturing, or commercialization processes, making it a determining condition for market access in Colombia.
The regulation also provides for specific exceptions, such as cases where no scientifically validated alternative methods exist or where data derive from tests conducted for other purposes, which must be duly justified before INVIMA.
This regulatory framework aligns with international trends promoting animal welfare and the development of alternative methods. Consequently, Colombia is consolidating a stricter regulatory framework with a global impact on cosmetics, raising compliance standards for the industry.
